41301-75-1

Basic information

• Product Name: 2-Cyclopenten-1-one, 2-[7-[[(4-methylphenyl)sulfonyl]oxy]heptyl]-, O-methyloxime
• CAS NO: 41301-75-1
• Molecular Formula: C20H29NO4S
• Molecular Weight: 379.521
• Mol File: 41301-75-1.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 2-Cyclopenten-1-one, 2-[7-[[(4-methylphenyl)sulfonyl]oxy]heptyl]-, O-methyloxime(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyclopenten-1-one, 2-[7-[[(4-methylphenyl)sulfonyl]oxy]heptyl]-, O-methyloxime(41301-75-1)
• EPA Substance Registry System: 2-Cyclopenten-1-one, 2-[7-[[(4-methylphenyl)sulfonyl]oxy]heptyl]-, O-methyloxime(41301-75-1)

Safety Data

• Hazardous Substances Data: 41301-75-1(Hazardous Substances Data)

Upstream product

• 52477-95-9 1-methoximino-2-(6,6-dicarboxyhexyl)-2-cyclopentene 
• 52477-96-0 1-methoximino-2-(6-carboxyhexyl)-2-cyclopentene 
• 5239-43-0 7-(5-oxo-1-cyclopenten-1-yl)heptanoic acid 
• 41301-67-1 1-acetoxy-2-(6-carbethoxyhexyl)-1-cyclopentene 
• 41301-73-9 1-methoximino-2-(6-carbethoxyhexyl)-2-cyclopentene 
• 40687-10-3 2-(6-ethoxycarbonylhexyl)cyclopentan-1-one 
• 40098-44-0 2-(6-ethoxycarbonylhexyl)-2-cyclopenten-1-one 
• 41301-74-0 1-methoximino-2-(7-hydroxyheptyl)-2-cyclopentene 
• 98-59-9 p-toluenesulfonyl chloride 

Relevant articles and documents

Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives

This disclosure describes certain 11-hydroxy and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

1-Alkoximino-2-(ω-substituted alkyl)-2-cyclopentenes

This disclosure describes certain 1-alkoximino-2-(ω-substituted-alkyl)-2-cyclopentenes useful as intermediates for the preparation of homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenoic acid and of 9-hydroxy-13-trans-prostenoic acid which have antimicrobial activity and prostaglandin-like hypotensive activity.

3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof

This disclosure describes compounds of the class of substituted 9-oxoprostanoic acids and the esters and cationic salts thereof, useful as antimicrobial agents, hypotensive agents, anti-ulcer agents, or as intermediates, and novel processes for preparing the same.